Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nitin Jain

Showing results (11-20 of 486) with videos related to

Pageof 49
Sort By:
Cancer Journal (Sudbury, Mass.)|November 26, 2019
The Shifting Paradigm in Chronic Lymphocytic Leukemia: Is Chemotherapy Still Relevant?Nitin Jain, Susan OʼBrien
Hematology/Oncology and Stem Cell Therapy|July 1, 2016
Immunofluorescence staining with an antipromyelocytic leukemia antibody for a rapid diagnosis of acute promyelocytic leukemiaAhmad Alhuraiji, Nitin Jain
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Update on signal inhibitors in chronic lymphocytic leukemiaPrajwal Boddu, Nitin Jain
Blood Reviews|January 19, 2016
Targeted therapies for CLL: Practical issues with the changing treatment paradigmNitin Jain, Susan O'Brien
Journal of Obstetrics and Gynaecology of India|November 5, 2014
Comment on case report entitled: adenomyosis of uterus with adenomyoma of fallopian tubeShaveta Jain, Nitin Jain
Hematology/Oncology Clinics of North America|August 7, 2013
Ibrutinib (PCI-32765) in chronic lymphocytic leukemiaNitin Jain, Susan O'Brien
Hematology. American Society of Hematology. Education Program|December 4, 2016
First-line therapy for young patients with CLLNitin Jain, Susan O'Brien
Blood|November 5, 2016
BCR inhibitor failure in CLL: an unmet needNitin Jain, Susan O'Brien
Emergency Medicine Journal : EMJ|July 13, 2012
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 4: Investigating flank pain: can the CT stay low?Nitin Jain, Sarah Robinson
Expert Opinion on Pharmacotherapy|November 18, 2010
Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignanciesNitin Jain, Olatoyosi Odenike
Pageof 49

Showing results (11-20 of 486) with videos related to

Sort By:
Pageof 49
Cancer Journal (Sudbury, Mass.)|November 26, 2019
The Shifting Paradigm in Chronic Lymphocytic Leukemia: Is Chemotherapy Still Relevant?Nitin Jain, Susan OʼBrien
Hematology/Oncology and Stem Cell Therapy|July 1, 2016
Immunofluorescence staining with an antipromyelocytic leukemia antibody for a rapid diagnosis of acute promyelocytic leukemiaAhmad Alhuraiji, Nitin Jain
Clinical Advances in Hematology & Oncology : H&O|May 10, 2018
Update on signal inhibitors in chronic lymphocytic leukemiaPrajwal Boddu, Nitin Jain
Blood Reviews|January 19, 2016
Targeted therapies for CLL: Practical issues with the changing treatment paradigmNitin Jain, Susan O'Brien
Journal of Obstetrics and Gynaecology of India|November 5, 2014
Comment on case report entitled: adenomyosis of uterus with adenomyoma of fallopian tubeShaveta Jain, Nitin Jain
Hematology/Oncology Clinics of North America|August 7, 2013
Ibrutinib (PCI-32765) in chronic lymphocytic leukemiaNitin Jain, Susan O'Brien
Hematology. American Society of Hematology. Education Program|December 4, 2016
First-line therapy for young patients with CLLNitin Jain, Susan O'Brien
Blood|November 5, 2016
BCR inhibitor failure in CLL: an unmet needNitin Jain, Susan O'Brien
Emergency Medicine Journal : EMJ|July 13, 2012
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 4: Investigating flank pain: can the CT stay low?Nitin Jain, Sarah Robinson
Expert Opinion on Pharmacotherapy|November 18, 2010
Emerging role of the histone deacetylase inhibitor romidepsin in hematologic malignanciesNitin Jain, Olatoyosi Odenike
Pageof 49